1. Rigo P, Paulus P, Kaschten B, Hustinx R, Bury T, Jerusalem G, Bénoit T, Foidart-Willems J (1996) Oncologic applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23:1641–1674
2. Conti P, Lilien D, Hawley K, Keppler J, Grafton ST, Bading JR (1996) PET and 18F in oncology: a clinical update. Nucl Med Biol 23:717–735
3. Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, Ido T (1991) Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-(methyl-14C)methionine, (6–3)thymidine and gallium-67. J Nucl Med 32:2118–2123
4. Wahl R, Clavo A (1993) Effects of hypoxia on cultured human tumor cell uptake of thymidine, L-methionine and FDG. J Nucl Med 34:73P
5. Minn H, Clavo A, Grenman R, Wahl R (1995) In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 36:252–258